News
- Author:
- Sara Freeman
Publish date: September 26, 2019
BARCELONA – How patients with type 1 disease monitor their glucose is more important than how insulin is delivere...
News
- Author:
- Sara Freeman
Publish date: September 25, 2019
BARCELONA – New data delve further into the differences in insulin sensitivity and glucose response in youth and adults with type 2 diabetes.
News
- Author:
- Sara Freeman
Publish date: September 24, 2019
BARCELONA – The primary endpoint of the study was not met, thus differences between the long-acting insulins could not be confirmed.
News
- Author:
- Sara Freeman
Publish date: September 20, 2019
BARCELONA – SUSTAIN 8 trial data show greater reductions in HbA1c and body weight with semaglutide ver...
News
- Author:
- Sara Freeman
Publish date: September 19, 2019
BARCELONA – Vildagliptin plus metformin provided greater and durable long-term benefits than metformin alone in p...
News
- Author:
- Sara Freeman
Publish date: July 22, 2019
MADRID – The investigational oral Janus kinase (JAK) 1 inhibitor filgotinib helped more patients achieve an ACR20 response at 12 weeks than did pl...
News
- Author:
- Sara Freeman
Publish date: July 21, 2019
MADRID – The EULAR recommendations also cover secondary prevention and management of recurrent episodes and catastrophic APS, for which new recomm...
News
- Author:
- Sara Freeman
Publish date: July 20, 2019
MADRID – Patients who had the shared epitope in HLA-DRB1 had better responses to abatacept than adalimumab in the phase 4 Early AMPLE trial.
News
- Author:
- Sara Freeman
Publish date: July 20, 2019
MADRID – Fatigue is a common and persistent problem affecting up to 80% of patients with rheumatoid arthritis and is severe in half of cases.
News
- Author:
- Sara Freeman
Publish date: July 19, 2019
MADRID – There was no difference in effectiveness outcomes or drug survival when switching to a second biologic with an alternate mechanism of act...
News
- Author:
- Sara Freeman
Publish date: July 8, 2019
MADRID – Already approved as a treatment for chronic plaque psoriasis, tildrakizumab (Ilumya) may also be beneficial in psoriatic arthritis, accor...
News
- Author:
- Sara Freeman
Publish date: July 8, 2019
MADRID – In a retrospective analysis, 79% of repeated antinuclear antibody tests for ANA-associated rheumatologic conditions remained the same.
Video
- Author:
- Sara Freeman
Publish date: July 3, 2019
MADRID – RSLV-132 improved fatigue symptoms in patients with primary Sjögren’s syndrome in the phase 2, randomized, proof-of-concept RESOLVE study....
News
- Author:
- Sara Freeman
Publish date: July 1, 2019
MADRID – The Assessment of SpondyloArthritis international Society (ASAS) has developed nine new quality standards to improve the management of ax...
Video
- Author:
- Sara Freeman
Publish date: June 28, 2019
MADRID – Genetic polymorphism in the Fc gamma receptor could be the reason why some patients with systemic lupus erythematosus do not respond to ri...
